MedTrace Logo

LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)

NCT06670651 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-06-10

No results posted yet for this study

Summary

To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.

Conditions

Interventions

DEVICE

total knee arthroplasty device

total knee arthroplasty device with ultracongruent bearing surface

Sponsors & Collaborators

  • LinkBio Corp.

    lead INDUSTRY

Principal Investigators

  • Brian Schwartz, MD · Illinois Bone & Joint Institute

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-21
Primary Completion
2031-12-31
Completion
2031-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06670651 on ClinicalTrials.gov